• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

构象激活和致癌性是由血小板生成素受体突变二聚体胞质边界螺旋结构缺失介导的。

Constitutive activation and oncogenicity are mediated by loss of helical structure at the cytosolic boundary of thrombopoietin receptor mutant dimers.

机构信息

Ludwig Institute for Cancer Research, Brussels, Belgium.

de Duve Institute, Université catholique de Louvain, Brussels, Belgium.

出版信息

Elife. 2023 Jun 20;12:e81521. doi: 10.7554/eLife.81521.

DOI:10.7554/eLife.81521
PMID:37338955
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10313314/
Abstract

Dimerization of the thrombopoietin receptor (TpoR) is necessary for receptor activation and downstream signaling through activated Janus kinase 2. We have shown previously that different orientations of the transmembrane (TM) helices within a receptor dimer can lead to different signaling outputs. Here we addressed the structural basis of activation for receptor mutations S505N and W515K that induce myeloproliferative neoplasms. We show using bone marrow reconstitution experiments that ligand-independent activation of TpoR by TM asparagine (Asn) substitutions is proportional to the proximity of the Asn mutation to the intracellular membrane surface. Solid-state NMR experiments on TM peptides indicate a progressive loss of helical structure in the juxtamembrane (JM) R/KWQFP motif with proximity of Asn substitutions to the cytosolic boundary. Mutational studies in the TpoR cytosolic JM region show that loss of the helical structure in the JM motif by itself can induce activation, but only when localized to a maximum of six amino acids downstream of W515, the helicity of the remaining region until Box 1 being required for receptor function. The constitutive activation of TpoR mutants S505N and W515K can be inhibited by rotation of TM helices within the TpoR dimer, which also restores helicity around W515. Together, these data allow us to develop a general model for activation of TpoR and explain the critical role of the JM W515 residue in the regulation of the activity of the receptor.

摘要

血小板生成素受体 (TpoR) 的二聚化对于受体的激活以及通过激活的 Janus 激酶 2 进行下游信号转导是必要的。我们之前已经表明,受体二聚体中跨膜 (TM) 螺旋的不同取向可以导致不同的信号输出。在这里,我们研究了导致诱导骨髓增生性肿瘤的受体突变 S505N 和 W515K 激活的结构基础。我们通过骨髓重建实验表明,TM 天冬酰胺 (Asn) 取代物导致的配体非依赖性 TpoR 激活与 Asn 突变与细胞内膜表面的接近程度成正比。TM 肽的固态 NMR 实验表明,随着 Asn 取代物接近细胞质边界,JM 区 R/KWQFP 基序中的螺旋结构逐渐丧失。在 TpoR 胞质 JM 区的突变研究表明,JM 基序中螺旋结构的丧失本身就可以诱导激活,但只有当 W515 下游最多六个氨基酸时,该结构才会丧失,Box1 之前的其余区域的螺旋性对于受体功能是必需的。TpoR 突变体 S505N 和 W515K 的组成性激活可以通过 TpoR 二聚体中 TM 螺旋的旋转来抑制,这也恢复了 W515 周围的螺旋性。总之,这些数据使我们能够开发出一种激活 TpoR 的一般模型,并解释了 JM W515 残基在调节受体活性中的关键作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1114/10313314/3d359c43a2ea/elife-81521-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1114/10313314/c7b6f43f71f1/elife-81521-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1114/10313314/e22fc98e4df8/elife-81521-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1114/10313314/845f32f1beee/elife-81521-fig2-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1114/10313314/e0eb4b82feb6/elife-81521-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1114/10313314/d5a16e6dceb6/elife-81521-fig3-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1114/10313314/a4a08fa1ba94/elife-81521-fig3-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1114/10313314/7d85c8c16a1e/elife-81521-fig3-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1114/10313314/325145089ee8/elife-81521-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1114/10313314/b8fae867e0b0/elife-81521-fig4-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1114/10313314/8bf4987ea4a3/elife-81521-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1114/10313314/0f6a2e369d21/elife-81521-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1114/10313314/b915d2a5c4ec/elife-81521-fig6-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1114/10313314/3d359c43a2ea/elife-81521-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1114/10313314/c7b6f43f71f1/elife-81521-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1114/10313314/e22fc98e4df8/elife-81521-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1114/10313314/845f32f1beee/elife-81521-fig2-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1114/10313314/e0eb4b82feb6/elife-81521-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1114/10313314/d5a16e6dceb6/elife-81521-fig3-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1114/10313314/a4a08fa1ba94/elife-81521-fig3-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1114/10313314/7d85c8c16a1e/elife-81521-fig3-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1114/10313314/325145089ee8/elife-81521-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1114/10313314/b8fae867e0b0/elife-81521-fig4-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1114/10313314/8bf4987ea4a3/elife-81521-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1114/10313314/0f6a2e369d21/elife-81521-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1114/10313314/b915d2a5c4ec/elife-81521-fig6-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1114/10313314/3d359c43a2ea/elife-81521-fig7.jpg

相似文献

1
Constitutive activation and oncogenicity are mediated by loss of helical structure at the cytosolic boundary of thrombopoietin receptor mutant dimers.构象激活和致癌性是由血小板生成素受体突变二聚体胞质边界螺旋结构缺失介导的。
Elife. 2023 Jun 20;12:e81521. doi: 10.7554/eLife.81521.
2
His499 Regulates Dimerization and Prevents Oncogenic Activation by Asparagine Mutations of the Human Thrombopoietin Receptor.组氨酸499调节二聚化并防止人血小板生成素受体天冬酰胺突变引起的致癌激活。
J Biol Chem. 2016 Feb 5;291(6):2974-87. doi: 10.1074/jbc.M115.696534. Epub 2015 Dec 1.
3
Tryptophan at the transmembrane-cytosolic junction modulates thrombopoietin receptor dimerization and activation.色氨酸在跨膜-胞质连接区调节血小板生成素受体二聚化和激活。
Proc Natl Acad Sci U S A. 2013 Feb 12;110(7):2540-5. doi: 10.1073/pnas.1211560110. Epub 2013 Jan 28.
4
Induction of myeloproliferative disorder and myelofibrosis by thrombopoietin receptor W515 mutants is mediated by cytosolic tyrosine 112 of the receptor.血小板生成素受体 W515 突变体诱导骨髓增生异常和骨髓纤维化是通过受体胞质酪氨酸 112 介导的。
Blood. 2010 Feb 4;115(5):1037-48. doi: 10.1182/blood-2008-10-183558. Epub 2009 Dec 8.
5
Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutants.骨髓增殖性肿瘤相关钙网蛋白突变体对血小板生成素受体的激活作用。
Blood. 2016 Mar 10;127(10):1325-35. doi: 10.1182/blood-2015-11-681932. Epub 2015 Dec 14.
6
MPL mutations in essential thrombocythemia uncover a common path of activation with eltrombopag dependent on W491.在原发性血小板增多症中,MPL 突变揭示了一种共同的激活途径,该途径依赖于 W491 与 eltrombopag 的结合。
Blood. 2020 Mar 19;135(12):948-953. doi: 10.1182/blood.2019003240.
7
Modulation of human thrombopoietin receptor conformations uncouples JAK2 V617F-driven activation from cytokine-induced stimulation.调控人血小板生成素受体构象可使 JAK2 V617F 驱动的激活与细胞因子诱导的刺激解耦联。
Blood. 2023 Nov 23;142(21):1818-1830. doi: 10.1182/blood.2022019580.
8
Thrombopoietin receptor down-modulation by JAK2 V617F: restoration of receptor levels by inhibitors of pathologic JAK2 signaling and of proteasomes.JAK2 V617F 导致血小板生成素受体下调:病理性 JAK2 信号和蛋白酶体抑制剂可恢复受体水平。
Blood. 2012 May 17;119(20):4625-35. doi: 10.1182/blood-2011-08-372524. Epub 2012 Feb 29.
9
Oncogenic CALR mutant C-terminus mediates dual binding to the thrombopoietin receptor triggering complex dimerization and activation.致癌性 CALR 突变体 C 端介导双重结合到血小板生成素受体触发复合物二聚化和激活。
Nat Commun. 2023 Apr 5;14(1):1881. doi: 10.1038/s41467-023-37277-3.
10
Effects of clinically relevant MPL mutations in the transmembrane domain revealed at the atomic level through computational modeling.通过计算建模从原子水平揭示临床相关 MPL 突变对跨膜结构域的影响。
PLoS One. 2011;6(8):e23396. doi: 10.1371/journal.pone.0023396. Epub 2011 Aug 17.

引用本文的文献

1
Structural basis of MPL activation by thrombopoietin.血小板生成素激活MPL的结构基础。
Blood Vessel Thromb Hemost. 2024 Jul 16;1(3):100018. doi: 10.1016/j.bvth.2024.100018. eCollection 2024 Sep.
2
Cryo-EM structure of the extracellular domain of murine Thrombopoietin Receptor in complex with Thrombopoietin.冷冻电镜结构解析鼠类血小板生成素受体胞外结构域与血小板生成素复合物
Nat Commun. 2024 Feb 7;15(1):1135. doi: 10.1038/s41467-024-45356-2.

本文引用的文献

1
Structure of a Janus kinase cytokine receptor complex reveals the basis for dimeric activation.Janus 激酶细胞因子受体复合物的结构揭示了二聚体激活的基础。
Science. 2022 Apr 8;376(6589):163-169. doi: 10.1126/science.abn8933. Epub 2022 Mar 10.
2
AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models.AlphaFold 蛋白质结构数据库:用高精度模型极大地扩展蛋白质序列空间的结构覆盖范围。
Nucleic Acids Res. 2022 Jan 7;50(D1):D439-D444. doi: 10.1093/nar/gkab1061.
3
Highly accurate protein structure prediction with AlphaFold.
利用 AlphaFold 进行高精度蛋白质结构预测。
Nature. 2021 Aug;596(7873):583-589. doi: 10.1038/s41586-021-03819-2. Epub 2021 Jul 15.
4
Tuning MPL signaling to influence hematopoietic stem cell differentiation and inhibit essential thrombocythemia progenitors.调节 MPL 信号转导以影响造血干细胞分化并抑制特发性血小板增多症祖细胞。
Proc Natl Acad Sci U S A. 2021 Jan 12;118(2). doi: 10.1073/pnas.2017849118.
5
A Conserved Proline Hinge Mediates Helix Dynamics and Activation of Rhodopsin.一个保守的脯氨酸铰链介导视紫红质的螺旋动力学和激活。
Structure. 2020 Sep 1;28(9):1004-1013.e4. doi: 10.1016/j.str.2020.05.004. Epub 2020 May 28.
6
Mechanism of homodimeric cytokine receptor activation and dysregulation by oncogenic mutations.同源二聚体细胞因子受体的激活机制及致癌突变的失调。
Science. 2020 Feb 7;367(6478):643-652. doi: 10.1126/science.aaw3242.
7
MPL mutations in essential thrombocythemia uncover a common path of activation with eltrombopag dependent on W491.在原发性血小板增多症中,MPL 突变揭示了一种共同的激活途径,该途径依赖于 W491 与 eltrombopag 的结合。
Blood. 2020 Mar 19;135(12):948-953. doi: 10.1182/blood.2019003240.
8
Influence of the familial Alzheimer's disease-associated T43I mutation on the transmembrane structure and γ-secretase processing of the C99 peptide.家族性阿尔茨海默病相关 T43I 突变对 C99 肽跨膜结构和 γ-分泌酶加工的影响。
J Biol Chem. 2019 Apr 12;294(15):5854-5866. doi: 10.1074/jbc.RA118.006061. Epub 2019 Feb 12.
9
Differential effect of inhibitory strategies of the V617 mutant of JAK2 on cytokine receptor signaling.JAK2 V617 突变体抑制策略对细胞因子受体信号的差异影响。
J Allergy Clin Immunol. 2019 Jul;144(1):224-235. doi: 10.1016/j.jaci.2018.12.1023. Epub 2019 Jan 29.
10
Receptor-mediated dimerization of JAK2 FERM domains is required for JAK2 activation.受体介导的 JAK2 FERM 结构域二聚化是 JAK2 激活所必需的。
Elife. 2018 Jul 25;7:e38089. doi: 10.7554/eLife.38089.